(1 - 6 von 6
)
Verleihungen - Deutsches Ärzteblattwww.aerzteblatt.de › archiv › Verleihungen
www.aerzteblatt.de
Djordje Atanackovic, II. Medizinische Klinik des Universitätsklinikums Hamburg-Eppendorf, für seine Forschung über die Impfung gegen Kopf-Hals-Tumoren. Phoenix- ...
MM - New Receptor Protein May Successfully Target JNCCN 360jnccn360.org › news › new-receptor-protein-may-su...
jnccn360.org
· ... our patients respond quite well to currently available immunotherapies, they relapsed as early as 1 year after treatment,” Djordje Atanackovic, ...
Preis an Krebsforscher verliehen
www.aerztezeitung.de
· Die UKE-Wissenschaftler Dr. Cenap Güngör und PD Dr. Djordje Atanackovic haben den mit Euro dotierten Forschungspreis der ...
New CAR T-cell Therapy for Multiple Myeloma Shows Promise in ...myelomaresearchnews.com › › car-tcell...
myelomaresearchnews.com
· The team is led by Djordje Atanackovic, MD, a university physician-scientist who in identified CD229 as a potential target for multiple ...
What is Multiple Myeloma? - WMARwww.wmar2news.com › infocus › what-is-multiple-...
www.wmar2news.com
vor 1 Tag · Dr. Djordje Atanackovic, the director of Cancer Immunotherapy at the University of Maryland's Greenbaum Comprehensive Cancer Center, ...
New CAR-T target yields promising results for | EurekAlert!
www.eurekalert.org
· The study was led by Djordje Atanackovic, MD, a physician-scientist at HCI and an associate professor of internal medicine, ...
sortiert nach Relevanz / Datum